| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Medical Officer
1 company
Shah Jatin is an EVP, Chief Medical Officer at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 1 buy and 6 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2022 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Medical Officer | Sell | 1,306 | $12.12 | $15,833.16 | -1.0% | -55.0% | -70.4% | |
| Feb 7, 2022 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Medical Officer | Sell | 1,704 | $9.86 | $16,804.85 | -1.3% | -50.7% | -65.6% | |
| May 7, 2021 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Medical Officer | Buy | 23,250 | $8.60 | $199,991.85 | +21.4% | -29.4% | -27.6% | |
| Feb 18, 2021 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Medical Officer | Sell | 1,186 | $14.83 | $17,589.80 | -2.2% | - | - | |
| Feb 11, 2021 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Medical Officer | Sale+OE | 1,748 | $15.52 | $27,127.39 | -3.5% | - | - | |
| Jul 15, 2020 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Medical Officer | Sale+OE | 589 | $19.46 | $11,461.94 | -1.3% | - | - | |
| Feb 19, 2020 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Medical Officer | Sell | 1,375 | $16.48 | $22,662.61 | -3.3% | - | - |